Skip to main content

Table 2 Detail and prevalence of multilocus genotypes in P. faciparum clinical samples from Gabi, Madarounfa, Maradi, Niger

From: Molecular markers of resistance to amodiaquine plus sulfadoxine–pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger

pfdhfr

pfdhps

pfmdr1

Haplotypes

N51I

C59R

S108N

I431V

S436A/F

A437G

A581G

A613S

N86Y

F184Y

N1042D

D1246Y

dhfr/dhps/mdr1

Number

Prevalence

I

C

S

I

S

G

A

A

N

Y

N

D

ICS/ISGAA/NYND

1

0.01

I

C

S

I

S

G

A

A

N

F

N

D

ICS/ISGAA/NFND

1

0.01

N

C

S

I

A

A

G

A

N

F

N

D

NCS/IAAGA/NFND

1

0.01

N

C

S

I

A

G

A

S

N

F

N

D

NCS/IAGAS/NFND

1

0.01

N

C

S

I

A

A

A

A

N

F

D

Y

NCS/IAAAA/NFDY

1

0.01

I

R

S

I

A

G

A

S

N

Y

N

D

IRS/IAGAS/NYND

1

0.01

I

R

N

I

S

G

A

A

N

Y

D

D

IRN/ISGAA/NYDD

1

0.01

N

R

N

I

A

G

A

A

N

F

N

D

NRN/IAGAA/NFND

1

0.01

I

R

N

I

A

A

A

A

N

F

N

D

IRN/IAAAA/NFND

1

0.01

I

R

S

I

A

G

A

S

N

F

N

D

IRS/IAGAS/NFND

1

0.01

I

C

N

I

A

G

A

A

N

F

N

D

ICN/IAGAA/NFND

1

0.01

I

C

N

V

A

G

A

A

N

F

N

D

ICN/VAGAA/NFND

1

0.01

I

R

N

I

A

A

A

A

N

F

D

D

IRN/IAAAA/NFDD

1

0.01

I

C

N

V

A

G

A

A

Y

F

N

D

ICN/VAGAA/YFND

1

0.01

I

R

N

I

A

A

A

S

N

F

N

D

IRN/IAAAS/NFND

1

0.01

I

R

N

I

F

G

A

S

N

Y

N

D

IRN/IFGAS/NYND

1

0.01

N

C

N

V

A

G

A

A

N

F

N

Y

NCN/VAGAA/NFNY

1

0.01

N

R

N

I

A

G

A

S

N

F

N

D

NRN/IAGAS/NFND

1

0.01

N

C

N

V

A

G

A

A

Y

F

N

Y

NCN/VAGAA/YFNY

1

0.01

I

R

N

I

F

G

A

S

N

F

N

D

IRN/IFGAS/NFND

1

0.01

I

R

N

V

A

G

A

A

N

F

N

D

IRN/VAGAA/NFND

1

0.01

I

R

N

V

A

G

A

A

Y

F

N

D

IRN/VAGAA/YFND

1

0.01

I

R

N

V

A

G

A

A

Y

F

N

Y

IRN/VAGAA/YFNY

1

0.01

N

C

S

I

A

A

A

A

N

F

N

D

NCS/IAAAA/NFND

2

0.02

N

C

S

I

A

G

A

A

N

F

N

D

NCS/IAGAA/NFND

2

0.02

I

R

N

I

S

A

A

A

N

F

N

D

IRN/ISAAA/NFND

2

0.02

I

R

N

I

S

G

A

A

N

F

N

Y

IRN/ISGAA/NFNY

2

0.02

I

R

N

I

S

A

A

A

N

Y

N

D

IRN/ISAAA/NYND

3

0.03

I

R

N

I

F

A

A

S

N

Y

N

D

IRN/IFAAS/NYND

3

0.03

I

R

N

I

F

A

A

S

N

F

N

D

IRN/IFAAS/NFND

3

0.03

I

R

N

I

A

G

A

S

N

F

N

D

IRN/IAGAS/NFND

3

0.03

N

C

S

I

A

A

A

A

N

F

D

D

NCS/IAAAA/NFDD

4

0.04

N

C

S

I

S

G

A

A

N

Y

N

D

NCS/ISGAA/NYND

7

0.08

I

R

N

I

S

G

A

A

N

Y

N

D

IRN/ISGAA/NYND

9

0.10

I

R

N

I

S

G

A

A

N

F

N

D

IRN/ISGAA/NFND

10

0.11

I

R

N

I

A

G

A

A

N

F

N

D

IRN/IAGAA/NFND

18

0.20

  1. Mutated residues are in italic